Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02482454
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
The First People's Hospital of Changzhou 50
Testing effectiveness (Phase 2)UnknownNCT02274584
What this trial is testing

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

Who this might be right for
Lymphomas
Peking University 20
Not applicableStudy completedNCT04616235
What this trial is testing

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

Who this might be right for
Interleukin-6 InhibitionPhysical StressAppetitive Behavior
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Ended earlyNCT02477787
What this trial is testing

Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS

Who this might be right for
Acute Myelogenous Leukemia
Asan Medical Center 77
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Testing effectiveness (Phase 2)UnknownNCT04676789
What this trial is testing

Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT00526292
What this trial is testing

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 12
Not applicableEnded earlyNCT00918658
What this trial is testing

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT05447078
What this trial is testing

Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection

Who this might be right for
Healthy Volunteers
University of Mississippi Medical Center 492
Not applicableEnded earlyNCT03164889
What this trial is testing

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Beijing 302 Hospital 80
Testing effectiveness (Phase 2)UnknownNCT03107962
What this trial is testing

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Mingzhi Zhang 20
Early research (Phase 1)Enrolling By InvitationNCT06518668
What this trial is testing

NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Hospital for Special Surgery, New York 6
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Testing effectiveness (Phase 2)Looking for participantsNCT03300492
What this trial is testing

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT07622940
What this trial is testing

Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma

Who this might be right for
Recurrent or Metastatic Esophageal AdenocarcinomaBiomarker-selected CLDN18.2-positive and/or HER2-positive Disease
Beijing Biotech 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02490735
What this trial is testing

CIK in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou 2,000
Not applicableUnknownNCT02978274
What this trial is testing

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Who this might be right for
Natural Killer Cell Mediated Immunity
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Study completedNCT04578210
What this trial is testing

Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia

Who this might be right for
Corona Virus Infection
Instituto de Investigación Hospital Universitario La Paz 84
Testing effectiveness (Phase 2)Looking for participantsNCT06733051
What this trial is testing

Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)

Who this might be right for
Natural Killer T-cell Lymphoma
Sun Yat-sen University 47
Next Page